ALB and diabetes mellitus: In this study, thiol-trioxidized albumin peptides in in vitro synthetic peptides and in vivo samples were identified and quantified by adopting a three-phase systematic approach, including discovery, targeted and validation phases, which quantitatively established the Cys trioxidation profile in 16 individual samples and revealed impaired plasma albumin in individuals with diabetes.